BioSpace News Archive

Business

Dr. William Dahut Named Chief Scientific Officer for the American Cancer Society

Dr. William Dahut has been named Chief Scientific Officer for the American Cancer Society.

April 19, 2022
·
2 min read
Pharm Country

Reulay Inc Announces Results From Study That Highlights the Effects of Reulay’s Digital Video and VR Platform for the Alleviation of Anxiety, Emotional Distress, and Distraction

Reulay, a research-backed mental health platform using AI to match anxiety states to brain-based interventions, today announced data that further underscores the effectiveness of Reulay’s digital video & VR therapeutics.

April 19, 2022
·
3 min read
ChoiceSpine™ Announces Full Market Release of Next Generation Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System

ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces today that it has launched its next-generation Harrier™ SA ALIF System.

April 19, 2022
·
3 min read
BioForest

AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at Life Science Innovation Northwest

AVM Biotechnology announced that Founder and Chief Science Officer, Dr. Theresa Deisher, will provide an invited company presentation as well as a poster presentation at Life Science Innovation Northwest taking place April 20-21, at the Washington State Convention Center in Seattle.

April 19, 2022
·
5 min read
Policy

Extended SpagoPix Patent Protection in Japan

Spago Nanomedical AB has received notice from the Japanese Patent Office that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D.

April 19, 2022
·
1 min read
Business

Cincinnati Children’s and CTI Announce Name and Managing Director of Joint Venture

Named Current Biologics, as a nod to both the cutting-edge technologies it will help develop and the Ohio River that connects Northern Kentucky and Cincinnati, the company will be led by Robert Preti, PhD.

April 19, 2022
·
5 min read
Deep Brain Stimulation Devices Market Size, Share, Report 2021-2030

The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by 2030 and it is estimated to expand at a CAGR of 5.1% from 2021 to 2030.

April 19, 2022
·
10 min read
Polymerase Chain Reaction (PCR) Market Size, Growth, Trends, Report 2021-2030

The global polymerase chain reaction (PCR) market size is expected to surpass US$ 8.1 Bn by 2030 and is estimated to expand at a CAGR of 6.4% from 2021 to 2030.

April 19, 2022
·
10 min read
Molecular Diagnostics Market to Witness Growth 11.1% By 2030

The global molecular diagnostics market size is expected to surpass around US$ 37.19 Bn by 2030 and it is estimated to expand at a CAGR of 11.1% from 2021 to 2030.

April 19, 2022
·
9 min read
Drug Development

Urovant Sciences Announces Publication of EMPOWUR Trial Subgroup Analysis Showing Similar Efficacy for GEMTESA® in Dry and Wet Overactive Bladder Populations

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the publication of a new, post-hoc analysis of data from the Phase 3 EMPOWUR trial of GEMTESA (vibegron) 75 mg in the International Journal of Clinical Practice.

April 19, 2022
·
8 min read